Cabaletta Bio, Inc. vs Pharmicell Co., Ltd.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pharmicell Co., Ltd. is the larger company by market value: $514 M against $343 M for Cabaletta Bio, Inc., 1.5 times as much (market caps of Oct 30, 2026 for Cabaletta Bio, Inc. and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Cabaletta Bio, Inc. CABA · #14,185 in the world | Pharmicell Co., Ltd. 005690.KS · #12,403 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇰🇷 South Korea |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $343 M | $514 M |
| Net income | $-168 M | — |
| Employees | 156 | — |
| Valuation | ||
| Price to book | 3.1× | — |
| Free cash flow yield | -38.6% | — |
| Profitability | ||
| Return on equity | -127.0% | — |
| Financial strength | ||
| Interest cover | -86.1× | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Cabaletta Bio, Inc. or Pharmicell Co., Ltd.?
Pharmicell Co., Ltd. is the larger company by market value: $514 M against $343 M for Cabaletta Bio, Inc., 1.5 times as much (market caps of Oct 30, 2026 for Cabaletta Bio, Inc. and Aug 1, 2026 for Pharmicell Co., Ltd.). Pharmicell Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
More about Cabaletta Bio, Inc.
More about Pharmicell Co., Ltd.
Sources#
Every figure on this page comes from these, with the date shown next to it.